To comply with a new (January 2020) legal interpretation of the Data Use Agreement between the U.S. Food and Drug Administration's Sentinel Initiative and the Centers for Medicare & Medicaid Services, the authors have made changes to the presentation of data in this article and the online supplementary material by *1*) masking cells with small numbers, *2*) masking certain cells that could be used to derive the cells with small numbers, *3*) adding an explanatory note in tables, and *4*) restricting analyses of diabetic ketoacidosis (DKA) rates to patients age ≥25 years. The following tables and figures are affected by these revisions:

Table 1

Figure 2

Figure 3

[Supplementary Tables 1, 2, 3, and 4](https://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc19-1481/-/DC1)

[Supplementary Figure 2](https://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc19-1481/-/DC1)

In addition, the following explanation was added under "Statistical Analysis" (Research Design and Methods section):

"Analyses of DKA rates were conducted among patients age ≥25 years due to few DKA events being observed among younger patients and a requirement by one of the data partners that cell sizes of 1 to 10 events not be displayed."

Data presented in the text under "DKA During Follow-up" (Results section) were revised to reflect the age-group restriction.

The online version of the article (<https://doi.org/10.2337/dc19-1481>) has been updated, and revised supplementary material has been posted at <http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc19-1481/-/DC1>.
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